| | Advisers to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Thursday to vote on whether to recommend the use of two COVID-19 vaccine boosters tailored against the Omicron variant. | | | A UN committee on Tuesday condemned the overturning of the constitutional right to abortion in the United States, saying it was hitting racial and ethnic minorities hardest and asked Washington to take mitigation measures. | | | A senior World Health Organization director has been placed on leave, a spokesperson confirmed on Tuesday, following staff accusations of bullying and other complaints. | | | Hungary must take action on changing its rule of law before it can receive any European Union recovery funds, the EU affairs chief of the Czech government, which holds the bloc's rotating presidency, said in an interview on Tuesday. | | | The United Nations-backed COVAX vaccine program will send 10 million doses of Pfizer /BioNTech COVID-19 shots for children to Mexico by the end of September, a senior Mexican official announced Tuesday. | | | It is possible to eliminate the monkeypox outbreak in Europe, World Health Organization officials said on Tuesday, highlighting evidence that case counts are slowing in a handful of countries. | | | Novartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs business Sandoz, as weaker drug prices and jittery financial markets present one of his biggest challenges in the years-long overhaul of the Swiss drugmaker. | | | AstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of heart failure, according to study data released on Saturday, opening the door to a substantial increase in patients who could benefit. | | | Several of China's biggest cities imposed tougher COVID-19 curbs on Tuesday, further crimping the activities of tens of millions, and sparking fresh concerns for the health of a barely growing economy. | | | Japan's health ministry said on Monday that its panel of experts had agreed to approve manufacturing and sales of AstraZeneca's COVID-19 preventive treatment Evusheld. | | | | |